Search Within

Min Yuen Teo

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (27)
  2. Journal Article (18)
  3. Editorial (1)
Groups
  1. Department of Medicine (46)
  2. Genitourinary Oncology Service (46)
  3. Human Oncology and Pathogenesis Program (46)
  4. Solid Tumor Oncology Division (46)
  5. Department of Pathology and Laboratory Medicine (42)
  6. GSK Faculty (42)

More Groups

People
  1. Gopakumar Iyer (45)
  2. David Solit (40)
  3. Dean Bajorin (40)
  4. Jonathan Rosenberg (40)
  5. Hikmat Al-Ahmadie (39)
  6. Bernard Bochner (31)

More People

Years
  1. 2025 (1)
  2. 2024 (6)
  3. 2023 (3)
  4. 2022 (9)
  5. 2021 (4)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Modern Pathology (4)
  3. Cancer Research (3)
  4. Clinical Cancer Research (3)
  5. Laboratory Investigation (3)
  6. European Urology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (23)
  2. American Association for Cancer Research (6)
  3. Nature Publishing Group (5)
  4. Nature Research (4)
  5. Cell Press (2)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (46)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cancer susceptibility mutations in patients with urothelial malignancies
    Journal Article

    Carlo, M. I.; Ravichandran, V.; Srinavasan, P.; Bandlamudi, C.; Kemel, Y.; Ceyhan-Birsoy, O.; Mukherjee, S.; Mandelker, D.; Chaim, J.; Knezevic, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Invasive urothelial cancer (iUC) with FGFR3 hotspot mutation/fusion (FGFR3+): A molecularly and clinically distinctive entity?
    Meeting Abstract

    Mota, J. M. S. C.; Teo, M. Y.; Li, H.; Balar, A. V.; Milowsky, M. I.; Funt, S. A.; Lee, C. H.; Regazzi, A. M.; Berger, M. F.; Solit, D. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Alterations in DNA damage repair (DDR) genes and outcomes to systemic therapy in 225 immune-oncology (10) versus tyrosine kinase inhibitor (TKI) treated metastatic clear cell renal cell carcinoma (mccRCC) patients (pts)
    Meeting Abstract

    Ged, Y.; Chaim, J.; Knezevic, A.; Carlo, M. I.; Foster, A.; Feldman, D. R.; Teo, M. Y.; Riaz, N.; Lee, C. H.; Patil, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • PD-L1 expression in urothelial carcinoma with predominant or pure variant histology: Concordance among 3 commonly used and commercially available antibodies
    Journal Article

    Reis, H.; Serrette, R.; Posada, J.; Lu, V.; Chen, Y. B.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Sirintrapun, S. J.; Iyer, G.; more...
    American Journal of Surgical Pathology (2019)

    Fulltext@MSK | Save
  • Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy
    Editorial

    Pietzak, E. J.; Zabor, E. C.; Bagrodia, A.; Armenia, J.; Hu, W.; Zehir, A.; Funt, S.; Audenet, F.; Barron, D.; Maamouri, N.; more...
    European Urology (2019)

    Fulltext@MSK | Save
  • Next generation sequencing of urothelial bladder cancer: Memorial Sloan Kettering Cancer Center experience in 454 patients
    Meeting Abstract

    Isharwal, S.; Audenet, F.; Drill, E. N.; Ostrovnaya, I.; Pietzak, E. J.; Al-Ahmadie, H.; Cha, E. K.; Donahue, T. F.; Teo, M. Y.; Funt, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Defining the DNA damage repair (DDR) genomic landscape of urothelial carcinoma of the bladder (UCB)
    Meeting Abstract

    Dason, S.; McPherson, V.; Teo, M. Y.; Isharwal, S.; Audenet, F.; Bagrodia, A.; Cha, E. K.; Berger, M. F.; Zehir, A.; Schultz, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Alterations in DNA damage response and repair genes as potential marker of clinical benefit from PD-1/PD-L1 blockade in advanced urothelial cancers
    Journal Article

    Teo, M. Y.; Seier, K.; Ostrovnaya, I.; Regazzi, A. M.; Kania, B. E.; Moran, M. M.; Cipolla, C. K.; Bluth, M. J.; Chaim, J.; Al-Ahmadie, H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression in urothelial carcinoma with divergent differentiation, concordance among three antibodies
    Meeting Abstract

    Reis, H.; Serrette, R. N.; Gopalan, A.; Chen, Y. B.; Fine, S. W.; Tickoo, S.; Sirintrapun, S. J.; Iyer, G.; Funt, S. A.; Teo, M. Y.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma
    Journal Article

    Teo, M. Y.; Bambury, R. M.; Zabor, E. C.; Jordan, E.; Al-Ahmadie, H.; Boyd, M. E.; Bouvier, N.; Mullane, S. A.; Cha, E. K.; Roper, N.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save